FINANCIAL POST

The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.

THE GLOBE AND MAIL

Tilray has raised $60-million to expand its growing capacity in Canada and Europe and to push its brand of medical cannabis products into a handful of new countries.

CBC NEWS

Following Germany, several other European countries, including Greece, Italy, Poland and the Czech Republic, passed new medical cannabis laws. That's led Tilray to begin construction of a $30-million production facility in Portugal to help supply the growing market.

CBC NEWS

Tilray Chief Executive Officer Brendan Kennedy discusses Tilray's Portugal expansion with CBC Business News.

THE NEW YORK TIMES

Tilray CEO Brendan Kennedy shared his insights about Canada's history-making effort to legalize and regulate adult-use cannabis. 

SHEKNOWS MEDIA

Discovering that CBD was an undeveloped potential anticonvulsant that might help thousands of children changed the course of my career. I’m now the clinical research director for Tilray, a medical cannabis company that provides patients with access to safe, reliable and consistent products to treat a wide variety of ailments.

THE GLOBE AND MAIL

Despite a Supreme Court of Canada decision that gives sick Canadians the right to use medical cannabis oils, Ottawa is reimbursing the country’s veterans for dried pot only, potentially pushing them to less healthy options of smoking or vaporizing the drug. Mr. Lucas, also head of patient services at Nanaimo-based grower Tilray, recently launched an e-petition sponsored by his local MP, New Democrat Sheila Malcolmson, asking Veterans Affairs to begin covering these extracts.

PBS NEWSHOUR

PBS speaks to neuroscientist Catherine Jacobson, who heads clinical research for Tilray, about how the company is trying to turn cannabis into conventional medicine.

BUSINESS NEWS NETWORK

Tilray, a Canadian cannabis producer, recently announced that it received approval to ship two varieties of liquid capsules to Croatia. Brendan Kennedy, Global President with Tilray says that Europe presents a good growth opportunity for Tilray.

FINANCIAL POST

The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.

THE GLOBE AND MAIL

Tilray has raised $60-million to expand its growing capacity in Canada and Europe and to push its brand of medical cannabis products into a handful of new countries.

CBC NEWS

Following Germany, several other European countries, including Greece, Italy, Poland and the Czech Republic, passed new medical cannabis laws. That's led Tilray to begin construction of a $30-million production facility in Portugal to help supply the growing market.

PBS NEWSHOUR

PBS speaks to neuroscientist Catherine Jacobson, who heads clinical research for Tilray, about how the company is trying to turn cannabis into conventional medicine.

CBC NEWS

Tilray Chief Executive Officer Brendan Kennedy discusses Tilray's Portugal expansion with CBC Business News.

THE NEW YORK TIMES

Tilray CEO Brendan Kennedy shared his insights about Canada's history-making effort to legalize and regulate adult-use cannabis. 

SHEKNOWS MEDIA

Discovering that CBD was an undeveloped potential anticonvulsant that might help thousands of children changed the course of my career. I’m now the clinical research director for Tilray, a medical cannabis company that provides patients with access to safe, reliable and consistent products to treat a wide variety of ailments.

THE GLOBE AND MAIL

Despite a Supreme Court of Canada decision that gives sick Canadians the right to use medical cannabis oils, Ottawa is reimbursing the country’s veterans for dried pot only, potentially pushing them to less healthy options of smoking or vaporizing the drug. Mr. Lucas, also head of patient services at Nanaimo-based grower Tilray, recently launched an e-petition sponsored by his local MP, New Democrat Sheila Malcolmson, asking Veterans Affairs to begin covering these extracts.

BUSINESS NEWS NETWORK

Tilray, a Canadian cannabis producer, recently announced that it received approval to ship two varieties of liquid capsules to Croatia. Brendan Kennedy, Global President with Tilray says that Europe presents a good growth opportunity for Tilray.

CBC NEWS

Canadian cannabis producer Tilray is placing its bets on budding demand from markets overseas as it begins shipping medical marijuana products to Croatia.

VICE NEWS

Tilray, based in British Columbia and one of the companies licensed by Canada's federal health ministry to produce and distribute medical cannabis, was recently granted an export permit. It's believed to be the first time a North American company has legally exported cannabis to the EU for commercial medical use.

WHAT SHE SAID RADIO (SIRIUSXM)

There are still far too many myths and misconceptions surrounding medical cannabis. On Tuesday, Dr. Catherine Jacobson, the Director of Clinical Research at Tilray, appeared on What She Said Radio to debunk those myths and answer some frequently asked questions. 

CTV VANCOUVER ISLAND

Tilray, one of Canada's largest medical marijuana producers, has opened the doors of its 65,000-square-foot, $30-million Nanaimo facility to give a rare glimpse of its production process. Company CEO Greg Engel answers five questions about the facility, its employees, legalization, and lessons for the industry.

WASHINGTON POST

Brendan Kennedy, president of Privateer Holdings of Seattle, welcomed the Canadian announcement. His company owns Tilray, a medicinal marijuana facility in British Columbia, and he is looking to build a facility that would supply the market for recreational marijuana in Canada.

THE GUARDIAN

As a mother, I am furious that the federal government has discouraged research into these potentially life-saving therapies for years by restricting clinical research. As a scientist, I decry the federal government for interfering with scientific freedom.

NATIONAL POST

These seismic global shifts in perception and policy have a deeply personal significance for me. As a scientist and director of clinical research at Tilray, one of Canada’s largest producers of medical cannabis, I welcome policies that open the doors for ground-breaking and potentially life-saving research.

VANCOUVER SUN

A B.C. company licensed by Health Canada could be involved in the first Canadian trial of CBD oil and epilepsy in adults. Nanaimo-based Tilray will provide CBD oil capsules to a team working with the Ontario Brain Institute.

THE GLOBE AND MAIL

Growers Aphria, Emerald Health Botanicals, MedReleaf, The Peace Naturals Project and Tilray helped sponsor this week’s event.

CTV NEWS

Tilray announced Monday that it has 20 cannabis extract products awaiting Health Canada approval, including oils in liquid form, gel caps and a topical preparation for certain skin conditions.

NATIONAL POST

A number of Canada’s medical marijuana growers are poised to release cannabis oils for authorized patients who don’t want to smoke or vaporize the dried herb to relieve their symptoms.

METRO NEWS

Nanaimo-based Tilray, one of Canada’s 26 licensed medical marijuana producers, wants to start selling oils and extracts. It still needs Health Canada approval.

CTV NEWS

An Alberta mother whose daughter has severe epilepsy has travelled to Ontario for a medical marijuana prescription after the girl's doctor said he was no longer allowed to provide permission to purchase the product.

THE GLOBE AND MAIL

An Alberta mother whose daughter has severe epilepsy has travelled to Ontario for a medical marijuana prescription after the girl’s doctor said he was no longer allowed to provide permission to purchase the product.

MAXIM

Marijuana is a $40 billion business — and the guys gearing up to turn ganja into the next McDonald's don't even smoke the stuff. Is the culture of weed about to go up in smoke, or are we just paranoid?

Canadian Medical Association Journal

Anecdotal reports of efficacy from patients who use medical marijuana aren’t enough to convince many physicians that cannabis is a viable therapeutic option, but new industry-funded research in Canada may bring some science to the situation. 

LIFT MAGAZINE

Three more Canadian medical cannabis producers have been issued production licenses for cannabis oils. Quebec’s Hydropothecary, BC’s Tilray and Saskatchewan’s Prairie Plant Systems (CanniMed) were all added to Health Canada’s production list today, after initially licensing BC’s Whistler Medical and Ontario’s Peace Naturals late last week.

BUSINESSWIRE

Pending regulatory approvals, the UBC-Tilray study is poised to be one of the first in the world to run a large-scale clinical trial examining medical cannabis as a treatment for a mental health disorder.

VANCOUVER SUN

A B.C. medical marijuana producer is seeking approval from Health Canada to sponsor the first study in Canada on the safety and effectiveness of cannabis for post-traumatic stress disorder (PTSD) among sexual assault victims, military veterans and first responder personnel.

THE GLOBE AND MAIL

Nanaimo-based Tilray has constructed a large, pristine operation on Vancouver Island, backed by Seattle private equity player Privateer Holdings, which has pumped considerable dollars into the U.S. tech sector over the years. The sprawling, brightly-lit facility is a testament to medical marijuana’s sanitized future, where staff wear white polyethylene suits and blue gloves when handling the plants.

WALL STREET JOURNAL

Private Equity Beat was on hand as Tilray held a ribbon-cutting ceremony April 28 to commence shipping its products. The company hopes to have the space, which is now 70% finished, completed by Sept. 1 with the expectation that it will serve about 8,000 patients.

NEW YORK TIMES

Tilray has since bought a building for $3.5 million and spent $17 million to renovate it. The company employs 65 people, with plans to increase that number to 100. “One hundred new jobs in a community of less than 100,000, that’s a big deal,” Mr. Kennedy said.

NANAIMO NEWS BULLETIN

“We’ve invested to produce cannabis on a scale unlike anything that’s currently available in Canada,” Kennedy said, adding that while other facilities he’s seen are dirty and inefficient, this one is the exact opposite. “We wanted everything to be clean.”

CBC NEWS

More than 400 people applied for about 60 positions at the Tilray plant near the Duke Point Ferry Terminal, including cultivators, security guards, and customer service, packaging, shipping and receiving representatives.